Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.3% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 45,313 shares of the medical equipment provider’s stock after selling 3,592 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Intuitive Surgical were worth $22,261,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of ISRG. International Assets Investment Management LLC increased its holdings in shares of Intuitive Surgical by 49,383.6% during the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock valued at $535,788,000 after purchasing an additional 1,088,415 shares in the last quarter. Capital Research Global Investors purchased a new position in Intuitive Surgical in the first quarter valued at $374,390,000. Strategic Financial Concepts LLC raised its position in shares of Intuitive Surgical by 40,221.4% in the second quarter. Strategic Financial Concepts LLC now owns 266,121 shares of the medical equipment provider’s stock worth $1,184,000 after acquiring an additional 265,461 shares during the period. GQG Partners LLC purchased a new stake in shares of Intuitive Surgical during the 1st quarter worth about $99,523,000. Finally, Canada Pension Plan Investment Board grew its position in shares of Intuitive Surgical by 36.4% during the 1st quarter. Canada Pension Plan Investment Board now owns 807,780 shares of the medical equipment provider’s stock valued at $322,377,000 after acquiring an additional 215,444 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 1.9 %

Shares of NASDAQ:ISRG opened at $527.61 on Friday. Intuitive Surgical, Inc. has a 52-week low of $295.02 and a 52-week high of $544.38. The stock has a market cap of $187.92 billion, a P/E ratio of 84.82, a PEG ratio of 5.19 and a beta of 1.39. The business has a fifty day moving average of $499.29 and a two-hundred day moving average of $457.89.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The firm had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Insider Activity

In other news, EVP Robert Desantis sold 396 shares of the company’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $486.88, for a total value of $192,804.48. Following the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,680,761.28. This represents a 6.71 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Jamie Samath sold 269 shares of the firm’s stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $539.89, for a total value of $145,230.41. Following the sale, the insider now directly owns 8,757 shares of the company’s stock, valued at $4,727,816.73. The trade was a 2.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 91,178 shares of company stock valued at $45,897,071 in the last 90 days. Company insiders own 0.90% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on ISRG. Royal Bank of Canada increased their price target on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research report on Friday, October 18th. The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a research note on Friday, October 18th. Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Redburn Atlantic raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and increased their price objective for the company from $380.00 to $510.00 in a report on Friday, August 2nd. Finally, Wells Fargo & Company boosted their target price on shares of Intuitive Surgical from $466.00 to $549.00 and gave the stock an “overweight” rating in a research note on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $513.74.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.